Angiogenesis and vasculogenesis in pregnancy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 110, Issue SUPPL., 2003, Pages

  Zygmunt, Marek ^a   Herr, Friederike ^a   Münstedt, Karsten ^a   Lang, Uwe ^a   Liang, Olin D ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; hCG; Pathology; Pregnancy; Tumor; Vasculogenesis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; CHORIONIC GONADOTROPIN; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; PROTEINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADAPTATION; ANGIOGENESIS; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; BONE MARROW; CANCER INVASION; CAPILLARY; CARCINOGENESIS; CELL ACTIVITY; CELL GROWTH; CELL INVASION; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; CONFERENCE PAPER; DECIDUA; ENDOMETRIUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; FETUS DEVELOPMENT; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HORMONE ACTION; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; MATERNAL BLOOD; MATERNAL DIABETES MELLITUS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN CONSUMPTION; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STEM CELL; TISSUE OXYGENATION; TROPHOBLAST; UTERUS BLOOD FLOW; VASCULARIZATION; VASODILATATION;

EID: 0041784889     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00168-4     Document Type: Conference Paper

References (109)

1. Poole T.J., Coffin J.D. Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J. Exp. Zool. 251(2):1989;224-231.
2. Risau W., Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:1995;73-91.
3. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M.et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5(4):1999;434-438.
4. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 173(2):1997;206-210.
5. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267(16):1992; 10931-10934.
6. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1(1):1995;27-31.
7. Hockel M., Schlenger K., Doctrow S., Kissel T., Vaupel P. Therapeutic angiogenesis. Arch. Surg. 128(4):1993;423-429.
8. Thompson W.D., Li W.W., Maragoudakis M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J. Pathol. 190(3):2000;330-337.
9. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235(4787):1987;442-447.
10. Reynolds L.P., Killilea S.D., Redmer D.A. Angiogenesis in the female reproductive system. FASEB J. 6(3):1992;886-892.
11. Torry R.J. Rongish angiogenesis in the uterus: potential regulation and relation to tumor angiogenesis. Am. J. Reprod. Immunol. 27(3-4):1992;171-179.
12. Risau W. Mechanisms of angiogenesis. Nature. 386(6626):1997;671-674.
13. Brooks P.C., Clark R.A. Cheresh DA requirement of vascular integrin alpha V beta 3 for angiogenesis. Science. 264(5158):1994;569-571.
14. Hammes H.P., Brownlee M., Jonczyk A., Sutter A., Preissner K.T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2(5):1996;529-533.
15. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrinol. Rev. 18(1):1997;4-25.
16. Galland F., Karamysheva A., Pebusque M.J., Borg J.P., Rottapel R., Dubreuil P.et al. The Flt-4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene. 8(5):1993;1233-1240.
17. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92(6):1998;735-745.
18. Zygmunt M., Mazzuca D., Han V. Human chorionic gonadotropin (hCG) induces VEGF expression in vitro. Placenta. 31:2000;A23.
19. Baird A., Klagsbrun M. The fibroblast growth factor family. Cancer Cells. 3(6):1991;239-243.
20. Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol. 3(2):1992;81-87.
21. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M.et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376(6535):1995;70-74.
22. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H. et al. Yancopoulos GD Increased vascularization in mice overexpressing angiopoietin-1. Science. 282(5388):1998;468-471.
23. Hayes A.J., Huang W.Q., Mallah J., Yang D., Lippman M.E., Li L.Y. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc. Res. 58(3):1999;224-237.
24. Dunk C., Shams M., Nijjar S., Rhaman M., Qiu Y., Bussolati B.et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am. J. Pathol. 156(6):2000; 2185-2199.
25. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79(2):1994;315-328.
26. DiPietro L.A., Polverini P.J. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am. J. Pathol. 143(3):1993;678-684.
27. Langer R., Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature. 263(5580):1976;797-800.
28. Ausprunk D.H., Knighton D.R., Folkman J. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and pre-existing graft blood vessels. Am. J. Pathol. 79(3):1975;597-628.
29. Nelson M.J., Conley F.K., Fajardo L.F. Application of the disc angiogenesis system to tumor-induced neovascularization. Exp. Mol. Pathol. 58(2):1993;105-113.
30. Norrby K., Jakobsson A., Sorbo J. Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol. Incl. Mol. Pathol. 52(3):1986;195-206.
31. Nehls V., Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 50(3):1995;311-322.
32. Feldmann H.J., Sievers K., Fuller J., Molls M., Lohr E. Evaluation of tumor blood perfusion by dynamic MRI and CT in patients undergoing thermoradiotherapy. Eur. J. Radiol. 16(3):1993;224-229.
33. Madjar H., Prompeler H.J., Sauerbrei W., Wolfarth R., Pfleiderer A. Color Doppler flow criteria of breast lesions. Ultrasound Med. Biol. 20(9):1994;849-858.
34. Kurjak A., Dudenhausen J.W., Hafner T., Kupesic S., Latin V., Kos M. Intervillous circulation in all three trimesters of normal pregnancy assessed by color Doppler. J. Perinat. Med. 25(4):1997;373-380.
35. Francis S.T., Duncan K.R., Moore R.J., Baker P.N., Johnson I.R., Gowland P.A. Non-invasive mapping of placental perfusion. Lancet. 351(9113):1998; 1397-1399.
36. Dennie J., Mandeville J.B., Boxerman J.L., Packard S.D., Rosen B.R., Weisskoff R.M. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn. Reson. Med. 40(6):1998;793-799.
37. Taylor J.S., Tofts P.S., Port R., Evelhoch J.L., Knopp M., Reddick W.E. et al. MR imaging of tumor microcirculation: promise for the new millennium. J. Magn. Reson. Imaging. 10(6):1999;903-907.
38. Yagel S., Anteby E.Y., Shen O., Cohen S.M., Friedman Z., Achiron R. Placental blood flow measured by simultaneous multigate spectral Doppler imagingin pregnancies complicated by placental vascular abnormalities. Ultrasound Obstet. Gynecol. 14(4):1999;262-266.
39. Findlay J.K. Angiogenesis in reproductive tissues. J. Endocrinol. 111(3):1986;357-366.
40. Jaffe R.B. Importance of angiogenesis in reproductive physiology. Semin. Perinatol. 24(1):2000;79-81.
41. Levin E.R., Rosen G.F., Cassidenti D.L., Yee B., Meldrum D., Wisot A.et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J. Clin. Invest. 102(11):1998;1978-1985.
42. Torry D.S., Holt V.J., Keenan J.A., Harris G., Caudle M.R., Torry R.J. Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril. 66(1):1996;72-80.
43. Hyder S.M., Stancel G.M. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol. Endocrinol. 13(6):1999;806-811.
44. Srivastava R.K., Gu Y., Ayloo S., Zilberstein M., Gibori G. Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line. J. Mol. Endocrinol. 21(3):1998;355-362.
45. Rider V., Psychoyos A. Inhibition of progesterone receptor function results in loss of basic fibroblast growth factor expression and stromal cell proliferation during uterine remodelling in the pregnant rat. J. Endocrinol. 140(2):1994;239-249.
46. Harris J., Ramsay E. The morphology of human uteroplacentare vasculature. Contrib. Embryo. 230:1966;45-57.
47. Burton G.J., Jauniaux E., Watson A. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181(3):1999;718-724.
48. Horn O. Histologische Studien über den menschlichen uterus. Berlin: Karger; 1918.
49. Beker JC. Aetiology of eclampsia, Br J Obstet Gynaecol 1948;756-65.
50. Rao CV. Novel concepts in neuroendocrine regulation of reproductive tract functions. In: The endocrinology of pregnancy. Totowa (NJ): Humana Press Inc.; 1998:125-44.
51. Zygmunt M., Hahn D., Munstedt K., Bischof P., Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta. 19(8):1998;587-593.
52. Zygmunt M., Herr F., Keller-Schönwetter S., Kunzi-Rapp K., Rao C.V., Lang U., Preissner K.T. Human chorionic gonadotropin (hCG) is an angiogenetic factor for uterine endothelial cells in vitro. J. Clin. Endocrinol. Metab. 87(11):2002;5290-5296.
53. Herr F, Lang U, Han VKM, Zygmunt M, IGF-II and its receptors in vascular adaptation to pregnancy. Placenta (21): A22.
54. Demir R., Kaufmann P., Castellucci M., Erbengi T., Kotowski A. Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat. (Basel). 136(3):1989;190-203.
55. Asan E., Kaymaz F.F., Cakar A.N., Dagdeviren A., Beksac M.S. Vasculogenesis in early human placental villi: an ultrastructural study. Anat. Anz. 181(6):1999;549-554.
56. Jackson M.R., Carney E.W., Lye S.J., Ritchie J.W. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta. 15(4):1994;341-353.
57. Sharkey A.M., Charnock-Jones D.S., Boocock C.A., Brown K.D., Smith S.K. Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil. 99(2):1993;609-615.
58. Shiraishi S., Nakagawa K., Kinukawa N., Nakano H., Sueishi K. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta. 17(2-3):1996;111-121.
59. Charnock-Jones D.S., Sharkey A.M., Boocock C.A., Ahmed A., Plevin R., Ferrara N.et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod. 51(3):1994;524-530.
60. Cooper J.C., Sharkey A.M., McLaren J., Charnock-Jones D.S., Smith S.K. Localization of vascular endothelial growth factor and its receptor, Flt, in human placenta and decidua by immunohistochemistry. J. Reprod. Fertil. 105(2):1995;205-213.
61. Clark D.E., Smith S.K., Sharkey A.M., Charnock-Jones D.S. Localization of VEGF and expression of its receptors Flt and KDR in human placenta throughout pregnancy. Hum. Reprod. 11(5):1996;1090-1098.
62. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J.et al. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Fact. 13(34):1996;243-250.
63. Hamai Y., Fujii T., Yamashita T., Kozuma S., Okai T., Taketani Y. Evidence for basic fibroblast growth factor as a crucial angiogenic growth factor, released from human trophoblasts during early gestation. Placenta. 19(2-3):1998;149-155.
64. Linzer D.I., Fisher S.J. The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol. Endocrinol. 13(6):1999;837-840.
65. Goldman-Wohl D.S., Ariel I., Greenfield C., Lavy Y., Yagel S. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol. Hum. Reprod. 6(1):2000;81-87.
66. Tamura T., Goldenberg R.L., Johnston K.E., Cliver S.P. Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstet. Gynecol. 91(3):1998;389-395.
67. Bouloumie A., Drexler H.C., Lafontan M., Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83(10):1998;1059-1066.
68. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C.et al. Biological action of leptin as an angiogenic factor. Science. 281(5383):1998;1683-1686.
69. te Velde E.A., Exalto N., Hesseling P., van der Linden H.C. First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum. Reprod. 12(7):1997;1577-1581.
70. Meegdes B.H., Ingenhoes R., Peeters L.L., Exalto N. Early pregnancy wastage: relationship between chorionic vascularization and embryonic development. Fertil. Steril. 49(2):1988;216-220.
71. Vuorela P., Carpen O., Tulppala M., Halmesmaki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol. Hum. Reprod. 6(3):2000;276-282.
72. Qiao S., Nagasaka T., Nakashima N. Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles. Int. J. Gynecol. Pathol. 16(3):1997;233-238.
73. Vailhe B., Dietl J., Kapp M., Toth B., Arck P. Increased blood vessel density in decidua parietalis is associated with spontaneous human first trimester abortion. Hum. Reprod. 14(6):1999;1628-1634.
74. van Beck E., Peeters L.L. Pathogenesis of pre-eclampsia: a comprehensive model. Obstet. Gynecol. Surv. 53(4):1998;233-239.
75. Dekker G.A., Sibai B.M. Etiology and pathogenesis of pre-eclampsia: current concepts. Am. J. Obstet. Gynecol. 179(5):1998;1359-1375.
76. Salafia C.M., Pezzullo J.C., Lopez-Zeno J.A., Simmens S., Minior V.K., Vintzileos A.M. Placental pathologic features of preterm pre-eclampsia. Am. J. Obstet. Gynecol. 173(4):1995;1097-1105.
77. Torry D.S., Wang H.S., Wang T.H., Caudle M.R., Torry R.J. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol. 179(6 Pt 1):1998;1539-1544.
78. Reuvekamp A., Velsing-Aarts F.V., Poulina I.E., Capello J.J., Duits A.J. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 106(10):1999;1019-1022.
79. Lyall F., Young A., Boswell F., Kingdom J.C., Greer I.A. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta. 18(4):1997;269-276.
80. Sharkey A.M., Cooper J.C., Balmforth J.R., McLaren J., Clark D.E., Charnock-Jones D.S.et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest. 26(12):1996;1182-1185.
81. Vuorela P., Matikainen M.T., Kuusela P., Ylikorkala O., Alitalo K., Halmesmaki E. Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet. Gynecol. 92(2):1998;179-183.
82. Cooper J.C., Sharkey A.M., Charnock-Jones D.S., Palmer C.R., Smith S.K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br. J. Obstet. Gynaecol. 103(12):1996;1191-1196.
83. Morrow R.J., Adamson S.L., Bull S.B.et al. Effect of placental embolization on the umbilical artery waveforms in fetal sheep. Am. J. Obst. Gynecol. 161:1989;1055-1060.
84. Nordenvall M., Ullberg U., Laurin G.et al. Placental morphology in relation to umbilical artery blood velocity waveforms. Eur. J. Obstet. Gynecol. Reprod. Biol. 40:1991;179-190.
85. Macara L., Kingdom J.C.P., Kaufmann P.et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta. 17:1996;37-48.
86. Teasdale F. Idiopathic intrauterine growth retardation: histomorphometry of the human placenta. Placenta. 5(1):1984;83-92.
87. Krebs C., Macara L.M., Leiser R., Bowman A.W., Greer I.A., Kingdom J.C.P. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental tree. Am. J. Obstet. Gynecol. 175:1996;1534-1542.
88. Jackson M.R., Walsh A.J., Morrow R.J., Mullen J.B., Lye S.J., Ritchie J.W.K. Reduced placental villous tree elaboration in small-for-gestational-age pregnancies: relationship with umbilical artery Doppler waveforms. Am. J. Obstet. Gynecol. 172(2):1995;518-525.
89. Hitschhold T., Weiss E., Beck T.et al. Low target birth weight in growth retardation? Umbilical Doppler velocity waveforms and histomorphic analysis of fetoplacental vascular tree. Am. J. Obstet. Gynecol. 168:1993;1260-1264.
90. Todros T., Sciarrone A., Piccoli E., Guiot C., Kaufmann P., Kingdom J. Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet. Gynecol. 93(4):1999;499-503.
91. Yagel S., Anteby E.Y., Shen O., Cohen S.M., Friedman Z., Achiron R. Simultaneous multigate spectral Doppler imaging of the umbilical artery and placental vessels: novel ultrasound technology. Ultrasound Obstet. Gynecol. 14(4):1999;256-261.
92. Jones C.J., Fox H. Placental changes in gestational diabetes. An ultrastructural study. Obstet. Gynecol. 48(3):1976;274-280.
93. Jacomo K.H., Benedetti W.L., Sala M.A., Alvarez H. Pathology of the trophoblast and fetal vessels of the placenta in maternal diabetes mellitus. Acta Diabetol. Lat. 13(56):1976;216-235.
94. Mayhew T.M., Sorensen F.B., Klebe J.G., Jackson M.R. Growth and maturation of villi in placentae from well-controlled diabetic women. Placenta. 15(1):1994;57-65.
95. Kami K., Mitsui T. Ultrastructural observations of chorionic villi at term in diabetic women. Tokai. J. Exp. Clin. Med. 9(1):1984;53-67.
96. Asmussen I. Vascular morphology in diabetic placentas. Contrib. Gynecol. Obstet. 9:1982;76-85.
97. Stoz F., Schuhmann R.A., Schmid A. Morphometric investigations of terminal villi of diabetic placentas in relationto the white classification of diabetes mellitus. J. Perinat. Med. 15(2):1987;193-198.
98. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1(2):1995;149-153.
99. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86(3):1996;353-364.
100. Berkman R.A., Merrill M.J., Reinhold W.C., Monacci W.T., Saxena A., Clark W.C.et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91(1):1993;153-159.
101. Plate K.H., Risau W. Angiogenesis in malignant gliomas. Glia. 15(3):1995;339-347.
102. Arbeit J.M., Olson D.C., Hanahan D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene. 13(9):1996;1847-1857.
103. Smith K., Fox S.B., Whitehouse R., Taylor M., Greenall M., Clarke J.et al. Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann. Oncol. 10(6):1999;707-713.
104. Jacquemier J., Adelaide J., Parc P., Penault-Llorca F., Planche J., de Lapeyriere O.et al. Expression of the FGFR1 gene in human breast-carcinoma cells. Int. J. Cancer. 59(3):1994;373-378.
105. Rak J., Filmus J., Finkenzeller G., Grugel S., Marme D., Kerbel R.S. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14(4):1995;263-277.
106. Rastinejad F, Bouck N. Oncogenes and tumor suppressor genes in the regulation of angiogenesis. In: Bicknell R, Lewis C, Ferrara N, editors. Tumor angiogenesis. Oxford University Press; 1997. p. 101-10.
107. Blood C.H., Zetter B.R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032(1):1990;89-118.
108. Denekamp J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev. 9(3):1990;267-282.
109. Endrich B., Hammersen F., Messmer K. Capillary ultrastructure and microcirculatory function of malignant tumors. Adv. Exp. Med. Biol. 242:1988;205-214.